Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques by Rune Byrkjeland et al.
Byrkjeland et al. Cardiovasc Diabetol  (2016) 15:13 
DOI 10.1186/s12933-016-0336-2
ORIGINAL INVESTIGATION
Effects of exercise training on carotid 
intima-media thickness in patients with type 2 
diabetes and coronary artery disease. Influence 
of carotid plaques
Rune Byrkjeland1,2,3*, Knut‑Haakon Stensæth4, Sigmund Anderssen5, Ida U. Njerve1,2,3, Harald Arnesen1,2,3, 
Ingebjørg Seljeflot1,2,3 and Svein Solheim1,2
Abstract 
Background: Carotid intima‑media thickness (cIMT) holds prognostic information for future cardiovascular disease 
and is associated with the extent of coronary atherosclerosis. We investigated the effect of exercise on cIMT progres‑
sion in patients with both type 2 diabetes and coronary artery disease (CAD).
Methods: Patients with type 2 diabetes and CAD (n = 137) were randomized to exercise training or standard follow‑
up. The 12 month exercise program contained 150 min weekly of combined aerobic and resistance training. High‑res‑
olution ultrasonography of the distal part of the common carotid artery (CCA) was performed to measure cIMT before 
and after the intervention. The CCA and the carotid bulb were scanned for the presence of atherosclerotic plaques. 
Differences in changes between the randomized groups were calculated by one‑way ANCOVA.
Results: In the total population no difference in changes of cIMT from baseline to 12 months was observed between 
the exercise group and controls [−0.016 mm (95 % CI −0.037 to 0.006) vs. −0.007 mm (95 % CI −0.029 to 0.015), 
p = 0.57]. However, there was a significant interaction between the effect of exercise training and the presence of 
carotid plaques (p = 0.013), and significant reduced cIMT was demonstrated in the exercise group compared with 
controls in patients without identified carotid plaques (n = 65) [−0.034 mm (95 % CI −0.060 to 0.008) vs. 0.013 mm 
(95 % CI −0.011 to 0.038), p = 0.010].
Conclusion: One year of exercise training in patients with type 2 diabetes and CAD did not significantly change cIMT 
progression. However, in patients without identified carotid plaques, beneficial effect of exercise training on cIMT 
progression was demonstrated.
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Background
Carotid intima-media thickness (cIMT) is an established 
marker of cardiovascular risk. Several studies have shown 
associations between cIMT and the risk for future car-
diovascular events in both healthy individuals, patients 
with type 2 diabetes and patients with known coronary 
artery disease (CAD) [1–3]. cIMT has also been used as 
a surrogate marker of generalised atherosclerosis and 
studies have shown associations between cIMT and 
the extent of atherosclerosis in the coronary arteries [4, 
5]. Further, Hodis et  al. showed that the progression of 
cIMT in patients with established CAD was predictive of 
coronary events and argued that cIMT changes in these 
patients reflected their underlying atherosclerotic pro-
gression [1].
Previous studies in patients with type 2 diabetes have 
shown reduced progression of cIMT after treatment of 
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cardiovascular risk factors like hyperglycemia and hyper-
tension, and changes in cIMT have been associated with 
changes in HbA1c [6]. Physical activity over long time 
may protect against atherosclerosis in healthy individual 
[7, 8], and in type 2 diabetes exercise and lifestyle inter-
vention may improve cardiovascular risk factors and 
attenuate cIMT progression [9, 10].
In patients with known CAD, previous studies with 
lifestyle and exercise interventions have shown attenu-
ated progression of coronary atherosclerosis [11, 12], 
although more recent exercise trials have indicated less 
anti-atherosclerotic effect of exercise in patients on statin 
treatment [13, 14].
Patients with type 2 diabetes have increased cIMT 
and their atherosclerotic disease is more accelerated and 
widespread compared to non-diabetic patients [6, 15, 
16]. Dyslipidemia and alterations in reverse cholesterol 
transfer, partly on genetic basis, may contribute to this 
[17–20]. Not many studies have investigated effects of 
exercise on cIMT or other measures of atherosclerosis in 
patents with both type 2 diabetes and CAD, and whether 
exercise has beneficial effect on the progression of ather-
osclerosis beyond up-to-date medical treatment in these 
patients is not clear.
The aim of the present study was therefore to inves-
tigate the effect of exercise training on cIMT progres-
sion in patients with the combination of type 2 diabetes 
and CAD. We hypothesised that exercise training would 
reduce the progression of cIMT in these patients.
Methods
Study design and participants
This study is part of a randomized clinical trial investi-
gating effects of exercise training on cardiovascular dis-
ease (CVD) risk factors and measures of atherosclerosis 
in patients with type 2 diabetes and CAD (ClinicalTrials.
gov: NCT01232608). Patients with known type 2 diabe-
tes and verified CAD by coronary angiography (n = 137) 
were included at the Department of Cardiology, Oslo 
University Hospital, Ullevål, Oslo, Norway between 
August 2010 and March 2012. The last follow-up was in 
March 2013. Exclusion criteria were presence of prolif-
erative retinopathy, end stage renal disease, cancer, stroke 
or acute myocardial infarction within the last 3 months, 
unstable angina, uncompensated heart failure, serious 
arrhythmia, severe valvular disease, severe rheumatologic 
disease, chronic obstructive pulmonary disease stadium 
GOLD IV, thromboembolic disease, ongoing infections, 
severe musculoskeletal disorders and other disabilities 
limiting the ability for physical activity. All patients gave 
informed, written consent to participate in the study. The 
study was approved by The Regional Ethics Commit-
tee and was conducted according to the Declaration of 
Helsinki. At the time of inclusion the patients were ran-
domized in a 1:1 ratio to either the exercise group or the 
control group. The control group continued with stand-
ard follow-up by their general practitioner. Study design 
and methods have also previously been reported [21].
Exercise intervention
The study participants randomized to the exercise group 
underwent a 12 months combined aerobic and resistance 
training program planned and conducted in collabora-
tion with the Norwegian School of Sports Sciences, Oslo, 
Norway. The exercise program consisted of group-based 
exercise sessions of 60 min duration twice a week under 
supervision of qualified instructors throughout the inter-
vention period, and a third weekly home-based individual 
exercise session. The total exercise volume was 150 min 
per week, of which approximately two-thirds was aerobic 
and one-third resistance exercises. The exercise sessions 
were guided by Borg’s scale of rated perceived exertion 
(RPE) and included parts of high intensity interval train-
ing (RPE ≥ 15) [21].
Anthropometric and laboratory measures
Body weight was measured with light clothing on the 
same weight before and after the intervention. Waist cir-
cumference was measured horizontally at the level of the 
iliac crest and at the end of a normal expiration. Arterial 
blood pressure (BP) was measured automatically in the 
brachial artery with patients in a supine position (Riester 
ri-champion® N, Jungingen, Germany). Blood samples 
were drawn at inclusion and end of the study by stand-
ard venipuncture between 0800 and 1000 AM after over-
night fast, without medication taken since the preceding 
evening and without exercise training the last 24 h. The 
final blood samples were taken within 1  week after the 
last exercise section. Total cholesterol, high-density lipo-
protein (HDL) cholesterol, triglyserides were determined 
by conventional laboratory methods. Low-density lipo-
protein (LDL) cholesterol was calculated by Friedewalds 
formula. HbA1c was measured by turbidimetric inhibi-
tion immunoassay (Roche, Basel, Switzerland) and CRP 
was determined by high sensitivity enzyme-linked immu-
nosorbent assay (DRG Instruments, Marburg/Lahn, 
Germany).
Common carotid artery ultrasonography
We implemented a standardized protocol and strict 
quality control procedures to achieve reliable ultrasonic 
measurements of the carotid artery IMT [22]. The sub-
jects were studied in the morning under standardized 
conditions (quiet room, comfortable temperature) and 
in the fasting state. One experienced sonographer who 
was blinded to the participants’ group status and risk 
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factor levels did all the examinations. High-resolution 
ultrasonography was performed with a Zonare z.one 
ultra (Zonare medical Systems, Mountain View, CA, 
USA) ultrasound scanner equipped with electrocardio-
gram (ECG) and a linear array 5–10  MHz transducer, 
using 8  MHz as centre frequency and utilizing the har-
monic frequencies. The participants were examined in 
the supine position with the head turned slightly to both 
sides. After identifying the bulb, longitudinal images 
of the common carotid artery (CCA) were obtained by 
combined B-mode and colour Doppler. The scan was 
focused on the far wall segment 20 mm proximal of the 
carotid bulb, where all measurements were done. All 
images were acquired by using an anterior oblique angle 
(30° from midline), and/or if needed, a lateral angle (100° 
from midline) [23, 24]. Measurements were taken during 
end-diastole (R-wave of the ECG) [25]. The CCA and the 
carotid bulb region were also scanned for the presence 
of atherosclerotic plaques, defined as a distinct area of 
the vessel protruding >50 % of the adjacent parts of the 
intima-media layer [26]. cIMT was measured at locations 
without atherosclerotic plaques, although plaques could 
be present in adjacent areas. The plaques’ volume and 
content (calcified, non-calcified, or mixed plaque) were 
analysed at baseline. Calculation of plaque volumes was 
based on manually set measurements of length, width 
and height of the plaques. All scans were digitally stored 
on the internal hard disk for subsequent off-line analysis 
using Osirix MD (v. 2.5.1) (Pixmeo, Geneva, Switzer-
land). Three end-diastolic frames were selected, and the 
mean cIMT was calculated for each subject as the aver-
age of maximum 9 (3  ×  3) consecutive measurements 
on each side. A minimum of two measurements on one 
side were needed to be included in the baseline analy-
ses and at least two measurements from the same side at 
both baseline and 12 months to be included in the inter-
val analyses. The intrasonographer variability has been 
shown earlier [22] [correlation coefficient for mean cIMT 
0.99 (0.977–0.999)].
Statistical analysis
The power calculations in the main study were based 
on an expected 10 % relative reduction of HbA1c in the 
exercise group while unchanged in the control group. 
Accounting for possible dropouts the calculations indi-
cated a minimum of 68 patients in each arm of the study 
[21].
Demographic data are given as proportions, mean 
(±SD) or medians (25, 75 percentiles) with skewed 
data. Between group differences in baseline character-
istics were calculated by independent-sample Students 
t-test, Chi square test or Mann–Whitney test as appro-
priate. Baseline associations were assessed by Pearson 
correlation or Spearman’s rank correlation as appropriate. 
Differences between the randomized groups in changes 
from baseline to 12 months were calculated by one-way 
ANCOVA. Skewed data distributions were log trans-
formed before entering the model. Within group changes 
in cIMT was calculated by paired-samples Student’s 
t-test. Changes are presented as mean [95 % confidence 
interval (CI)]. Interactions between the exercise effect on 
cIMT and relevant baseline factors were investigated by 
two-way ANCOVA. Based on clinical judgement, the fol-
lowing factors were considered potential effect modifiers 
(continuous variables were dichotomized at median val-
ues): Gender, etnicity (caucasian), age (>64), body mass 
index (BMI) (>29  kg/m2), previous myocardial infarc-
tion, presence of carotid plaques, years of known diabetes 
(>9), presence of microvascular complications, baseline 
LDL (>2.0 mmol/L) and baseline HbA1c (>7.4 %). SPSS 
version 18.0 for Windows was used. p value  <  0.05 was 
defined as statistically significant.
Results
Flow chart of the study population, dropouts and exer-
cise adherence have been reported in detail elsewhere 
[21]. In summary, 123 patients completed the study 
with eight dropouts in the exercise group and six in the 
control group. Baseline characteristics of the study sub-
jects are shown in Table  1. No patients were in NYHA 
class > II (angina or dyspnea). Due to plaque burden and 
technical challenges baseline cIMT measurements were 
determined in 117 patients, whereas valid measurements 
of changes in cIMT (according to the protocol) were 
obtained in 104 patients. There were no significant dif-
ferences between the randomized groups at baseline, and 
baseline characteristics did not differ between patients 
included in the cIMT analyses or not.
Carotid IMT and plaques at baseline
The overall mean cIMT at baseline was 0.866 mm ± 0.180 
in males (age 63.3  ±  7.8), and 0.793  mm  ±  0.102 in 
females (age 61.7 ±  8.8). Baseline cIMT was correlated 
to age in men (n =  115) (r =  0.343, p < 0.001), but did 
not reach statistical significance in women (n  =  22) 
(r = 0.321, p = 0.17). There was a significant correlation 
between cIMT and LDL cholesterol in men (r =  0.222, 
p = 0.023), but not in women (p = 0.92).
Fifty-eight patients (50  %) were identified as having 
carotid plaques. Of these, 42 patients had a single domi-
nating plaque with a median volume of 97  mm3 (63, 
142). These single plaques were classified as calcified 
(n = 9), non-calcified (n = 9) or mixed (n = 24). There 
was no significant difference in the presence of plaques 
between the randomized groups (p = 0.18). Patients with 
plaques were older (65.5 years ± 6.7 vs. 61.5 years ± 7.8, 
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p  =  0.003), had a lower proportion of non-Cauca-
sians (5.2  % vs. 23.1  %, p  =  0.011), higher systolic BP 
(143  mmHg ±  16 vs. 136  mmHg ±  16, p =  0.012) and 
higher cIMT (0.905 mm ± 0.195 vs. 0.826 mm ± 0.139, 
p = 0.014) compared to patients without plaques.
Changes in cIMT
We could not demonstrate any significant difference 
between the exercise group and control group in changes 
of cIMT from baseline to 12 months in the overall pop-
ulation [−0.016  mm (−0.037 to 0.006) vs. −0.007  mm 
(−0.029 to 0.015), p = 0.57] (Table 2). The non-significant 
reduction of cIMT in the exercise group (p = 0.19), cor-
related with change in systolic BP (r = 0.279, p = 0.041) 
and tended to correlate with change in HbA1c (r = 0.254, 
p  =  0.064), but not with change in LDL cholesterol 
(p = 0.55).
The identification of carotid plaques interacted with 
the effect of exercise on cIMT progression (Table 3). In 
the strata of patients without plaques, cIMT decreased 
significantly in the exercise group compared to controls 
[−0.034  mm (−0.060 to −0.008) vs. 0.013  mm (−0.011 
Table 1 Baseline characteristics of  all included patients and  patients completing the study in  the randomized groups 
(n = 123)
Data are presented as proportions or mean ± SD if not otherwise stated
BMI body mass index, PCI percutanous coronary intervention, CABG coronary artery bypass grafting, NYHA New York Heart Association functional classification of 
dyspnea, ACE angiotensin converting enzyme, ARB angiotensin receptor II blocker, CCB calcium channel blockers
p value refers to between group differences at baseline in patients who completed the study
a No significant between group differences
b Median (25, 75 percentiles)
c Defined as known diabetes microvascular complications, albuminuria (including micro-) and/or positive monofilament test at baseline
Characteristics All (n = 137)a Exercise (n = 61) Control (n = 62) p value
Age (years) 63.1 ± 7.9 63.5 ± 8.0 63.2 ± 7.2 0.82
Gender (male/female), n 115/22 54/7 50/12 0.34
Ethnicity (Caucasian/non‑Caucasian), n 114/23 53/8 52/10 0.83
Current smoker, n (%) 23 (17) 10 (16) 9 (15) 0.97
Previous smokers, n (%) 65 (47) 30 (50) 30 (50) 1.00
BMI (kg/m2) 29.2 ± 5.0 29.2 ± 4.0 29.0 ± 5.6 0.80
Waist circumference (cm) 106.1 ± 12.7 106.7 ± 11.2 105.3 ± 14.2 0.55
Years of diabetesb 9 (5, 15) 10 (5, 15) 9 (5, 13) 0.48
Microvascular complicationsc, n (%) 55 (40) 24 (39) 23 (37) 0.94
Hypertension, n (%) 100 (73) 45 (74) 46 (74) 1.00
Angina pectoris, n (%) 51 (37) 25 (41) 26 (42) 1.00
Previous myocardial infarction, n (%) 62 (45) 25 (41) 31 (50) 0.41
Years since myocardial infarctionb 3 (1, 11) 3 (1, 11) 3 (1, 11) 0.92
Previous PCI, n (%) 92 (67) 37 (61) 46 (74) 0.16
Previous CABG, n (%) 38 (28) 17 (28) 19 (31) 0.89
Chronic heart failure, n (%) 11 (8) 2 (3) 5 (8) 0.45
NYHA class II, n (%) 30 (22) 9 (15) 18 (29) 0.090
HbA1c (%)b 7.4 (6.8, 8.3) 7.3 (6.8, 8.3) 7.3 (6.8, 7.9) 0.90
Creatinine (μmol/L)b 79 (68, 91) 78 (69, 91) 67 (81, 88) 0.92
Medication, n (%)
 Anti‑platelet therapy 129 (94) 56 (92) 61 (98) 0.20
 Statins 128 (93) 57 (93) 58 (94) 1.00
 Beta‑blockers 106 (77) 49 (80) 48 (77) 0.86
 ACE‑inhibitors/ARB 97 (70) 39 (64) 46 (74) 0.30
 CCB 45 (33) 19 (31) 21 (34) 0.85
 Metformin 101 (74) 47 (77) 46 (74) 0.87
 Sulfonylurea 48 (35) 25 (41) 17 (27) 0.16
 Gliptins 17 (12) 6 (10) 11 (18) 0.31
 Insulin/insulin‑analogues 26 (19) 10 (16) 12 (19) 0.85
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to 0.038), p = 0.010] (Fig. 1), still significant after adjust-
ing for CVD risk factors at baseline (smoking, LDL cho-
lesterol, systolic blood pressure, HbA1c, gender and age) 
(p  =  0.003). There was no difference between patients 
with and without carotid plaques in exercise adherence 
during the intervention (p = 0.68).
Changes in cardiovascular risk factors
We have previously reported no overall significant 
changes in the exercise group compared to controls in 
HbA1c [−0.22  % (−0.49 to 0.04) vs. −0.01  % (−0.25 to 
0.24), p = 0.24], weight [−0.9 kg (−1.8 to 0.1) vs. 0.3 kg 
(−0.6 to 1.2), p = 0.087] or waist circumference (0.9 cm 
(−0.4 to 2.3) vs. 2.3 cm (1.0 to 3.6), p = 0.153) [21]. We 
could also not demonstrate any significant differences 
between the randomized groups in changes of BP, HDL 
cholesterol or CRP, whereas LDL cholesterol increased in 
the exercise group compared to controls (Table 2). When 
analysed according to the presence of carotid plaques, 
there were no differences in changes of the risk factors, 
except for LDL cholesterol levels which increased in the 
exercise group compared to controls in patients with 
plaques [0.20  mmol/L (0.00 to 0.41) vs −0.13  mmol/L 
Table 2 Carotid intima-media thickness, blood pressure and serum lipids at baseline and after 12 months
Data are presented as mean ± SD if not otherwise stated
cIMT carotid intima-media thickness, SBP/DBP systolic/diastolic blood pressure, TC total cholesterol, LDL low density lipoprotein cholesterol, HDL high density 
lipoprotein cholesterol, TG triglycerides. CRP c-reactive protein
p value refers to difference between the groups in changes from baseline to 12 months (one-way ANCOVA). * p < 0.05, within-group changes from baseline to 
12 months
a No significant between group differences








Baseline Baseline 12 months Baseline 12 months
cIMT (mm) 0.855 ± 0.172 0.876 ± 0.187 0.858 ± 0.175 0.853 ± 0.141 0.849 ± 0.131 0.57
SBP (mmHg) 139 ± 17 139 ± 17 140 ± 17 139 ± 16 139 ± 16 0.75
DBP (mmHg) 79 ± 9 78 ± 9 79 ± 9 80 ± 9 80 ± 10 0.51
TC (mmol/L)b 3.9 (3.4, 4.5) 3.8 (3.4, 4.3) 3.9 (3.3, 4.6) 4.0 (3.3, 4.7) 3.7 (3.2, 4.5)* 0.014
LDL (mmol/L)b 2.0 (1.6, 2.6) 1.9 (1.6, 2.5) 2.0 (1.7, 2.7)* 2.1 (1.6, 2.7) 1.9 (1.5, 2.7)* 0.020
HDL (mmol/L)b 1.12 (0.94, 1.40) 1.12 (0.96, 1.32) 1.11 (0.93, 1.41) 1.13 (0.93, 1.40) 1.09 (0.94, 1.34) 0.080
TG (mmol/L)b 1.40 (1.07, 1.88) 1.43 (1.09, 1.91) 1.53 (1.10, 1.99) 1.38 (0.98, 1.89) 1.38 (0.87, 2.01) 0.20
CRP (mg/L)b 2.41 (1.15, 4.99) 2.04 (0.95, 4.40) 1.99 (1.00, 4.21) 2.40 (1.19, 4.98) 1.77 (0.96, 3.86) 0.91
Table 3 Interaction with exercise effect on carotid intima-
media thickness
BMI body mass index, LDL low density lipoprotein cholesterol
p value for interaction calculated by two-way ANCOVA
a Median value
b Detected by scanning of the common carotid artery and the carotid bulb 
region during ultrasonography
c Defined as known diabetes microvascular complications, albuminuria 





BMI (>29 kg/m2)a 0.20
Previous myocardial infarction 0.70
Presence of carotid plaquesb 0.013
Years of known diabetes (>9)a 0.20
Microvascular complicationsc 0.71
LDL (>2.0 mmol/L)a 0.21
HbA1c (>7.4 %)a 0.28
Fig. 1 Absolute change in carotid intima‑media thickness (cIMT) 
(mm) in patients without carotid plaques (n = 65) according to the 
randomized groups, illustrated as mean (95 % confidence interval). p 
value refers to the difference in changes from baseline to 12 months 
between the groups (one‑way ANCOVA)
Page 6 of 8Byrkjeland et al. Cardiovasc Diabetol  (2016) 15:13 
(−0.37 to 0.12), p =  0.044], but not in patients without 
plaques (p = 0.40).
Discussion
The main finding in this study was that 1  year of exer-
cise training did not significantly change cIMT progres-
sion in patients with type 2 diabetes and CAD. However, 
the identification of carotid plaques interacted with the 
exercise effect and in patients without plaques cIMT 
decreased significantly in the exercise group compared to 
controls. These results indicate minor benefits of exercise 
training on the progression of atherosclerosis beyond 
up-to-date medical treatment in patients with type 2 dia-
betes and CAD. Nevertheless, local severity of athero-
sclerosis, assessed by the presence of carotid plaques  in 
this study, may influence the effects of exercise, and 
attenuated progression seems to occur in vascular areas 
without advanced atherosclerotic disease.
No overall change in cIMT progression
Exercise training has numerous beneficial effects in 
patients with either type 2 diabetes or CAD, and exercise 
plays an important role in the management of type 2 dia-
betes and in cardiac rehabilitation [9, 27, 28]. However, 
there is limited data on the effect of exercise in high-risk, 
complicated patients with the combination of type 2 dia-
betes and CAD.
Our main result indicates limited effects of exercise on 
cIMT progression in these patients beyond up-to-date 
medical treatment. This is in accordance with previous 
studies showing that the use of statins may influence the 
effect of exercise on the progression of cIMT/atheroscle-
rosis. In statin treated patients with either CAD or hyper-
tension, studies have not demonstrated reduced cIMT 
progression after exercise training [14, 29]. A recent study 
with multifactorial lifestyle intervention in patients with 
both type 2 diabetes and CAD also showed no effect on 
progression of atherosclerosis evaluated by intravascular 
ultrasound, although endothelial function did improve [30].
On the other hand, studies of healthy individuals and 
type 2 diabetic patients without statin treatment have 
demonstrated reduced progression of cIMT after exer-
cise or lifestyle intervention [10, 13]. Lifestyle interven-
tions in patients with CAD before the statin era also 
showed reduced progression of atherosclerosis [11, 12]. 
These results indicate that lipid-lowering treatment with 
statins may attenuate the additional benefits of exercise 
on cIMT/atherosclerosis progression, and this may have 
contributed to the overall neutral result in our study.
Other pharmacological treatments may also influ-
ence cIMT progression and thus the result of the pre-
sent trial. Studies in patients with type 2 diabetes have 
shown that aspirin, enalapril, calcium channel blockers 
and metformin in combination with glibenclamide, may 
attenuate cIMT progression, independent of their impact 
on glycemic control and BP [6, 31].
We observed only small changes in CVD risk fac-
tors in the present study. Systolic BP and HbA1c did 
not decrease significantly, and as previous studies in 
patients with type 2 diabetes have shown associations 
between improvements of BP and HbA1c and reduction 
of cIMT progression [6, 31], this may have contributed 
to the minor change in cIMT. We confirmed these asso-
ciations in the present study. The levels of CRP did also 
not change during the study, indicating that the exercise 
intervention did not have a significant anti-inflammatory 
effect in this population.
LDL cholesterol increased significantly in the exercise 
group compared to controls. This result stands in con-
trast to a minor reduction that could be expected after 
exercise in patients with type 2 diabetes only [9]. How-
ever, in patients with CAD or multiple cardiovascular 
risk factors metaanalyses of exercise interventions have 
not demonstrated beneficial change in LDL choles-
terol [32, 33]. The patients in the present study all had 
CAD and type 2 diabetes, and most of them several 
other CVD risk factors in addition. Taken together, this 
may indicate that exercise has less beneficial, or even 
unbeneficial, effect on LDL cholesterol in patients with 
more complicated vascular disease. Interestingly, our 
subgroup analyses showed increased LDL cholesterol 
in patients with identified carotid plaques, but not in 
patients without plaques. Nevertheless, we observed no 
correlation between the changes in LDL cholesterol and 
cIMT, implying that the increase in LDL cholesterol did 
not influence cIMT progression during the study period. 
Others have also suggested that changes in LDL choles-
terol levels are more strongly related to changes in plaque 
characteristics than to changes in absolute cIMT [6, 34].
The exercise modality in the present study may have 
contributed to the overall neutral result. Kadoglou et al. 
showed that only aerobic training ameliorated cIMT in 
patients with type 2 diabetes, and not resistance training 
or combined aerobic and resistance training [35].
Cesar et  al. also discussed the limitations of exercise 
only to reduce established atherosclerosis. In an animal 
model they demonstrated that exercise is beneficial to 
reduce atherosclerosis only when combined with dietary 
intervention [36].
Reduced cIMT in patients without carotid plaques
The identification of carotid plaques in the present study 
indicates severe atherosclerotic disease in adjacent vas-
cular areas from where cIMT was measured. The pres-
ence of such plaques interacted with the exercise effect 
on cIMT, and we observed reduced cIMT in the exercise 
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group compared to controls in patients without plaques. 
These results indicate that exercise may reduce cIMT/
atherosclerosis development in vascular areas with no 
or early stages of atherosclerotic disease, whereas the 
anti-atherosclerotic effects of exercise is attenuated in 
areas with advanced atherosclerotic lesions. This may 
be discussed along with previous studies demonstrating 
paradoxical vasoconstriction during exercise in coronary 
arteries with significant atherosclerotic disease, whereas 
vasodilation occurred as expected in coronary arteries 
without signs of atherosclerosis [37, 38]. These results 
imply that the presence of atherosclerotic plaques inter-
feres with endothelial function and disturbs the normal 
vasodilatory effect of exercise, possibly through reduced 
production and release of nitric oxid (NO). Knowing 
that NO also induces important anti-atherosclerotic 
responses, a possible explanation of our subgroup results 
is that the carotid vascular segments with plaques expe-
rience weaker NO-mediated effects of exercise com-
pared to areas without plaques, where these beneficial 
responses to a greater extent are preserved.
To summarise, our results indicate that 12  months of 
combined aerobic and resistance exercise training without 
dietary intervention does not reduce progression of ath-
erosclerosis in up-to-date medical treated patients with 
both type 2 diabetes and CAD. However, the local severity 
of atherosclerosis may influence the exercise effect and an 
attenuation of further atherosclerotic development may 
occur in less affected vascular areas. Thus, our results do 
not undermine the overall importance of physical activity 
and exercise, and patients with type 2 diabetes and CAD 
should be encouraged to regular exercise. Nevertheless, 
the results implicate that the anti-atherosclerotic effects 
of exercise are the most pronounced with milder or earlier 
stages of atherosclerotic disease.
Limitations
The follow-up time in the present study was 12 months 
and this is relatively short time when studying the devel-
opment and progression of atherosclerotic disease. Physi-
cal exercise may also be considered a “weak” intervention 
that require extra-long follow-up. Thus, the duration of 
our study may have been too short for an actual differ-
ence between the groups to occur.
Another limitation of the study was that atheroscle-
rosis was only evaluated at one specific vascular site. As 
the progression of atherosclerosis may vary between dif-
ferent vascular areas, this limit the interpretation of the 
results at an individual level.
The power calculations in the main study were based on 
an expected change in HbA1c and this may have made it 
underpowered for the investigation of cIMT progression.
Conclusion
One year of exercise training in patients with both type 
2 diabetes and CAD did not significantly change cIMT 
progression. Up-to-date medication and minor changes 
in CVD risk factors during the intervention period may 
have contributed to this result. However, the identifi-
cation of carotid plaques interacted with the effect of 
exercise on cIMT and a significant reduction in cIMT 
progression was demonstrated in patients without 
plaques. This indicates that the severity of local carotid 
atherosclerosis may influence the effect of exercise on 
cIMT progression and that beneficial change could be 
expected with less severe atherosclerotic disease.
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